A customer-centric, innovative and reliable CDMO
Porton Pharma With our 4900+ skilled employees working across 20+ sites around the globe, Porton Pharma Solutions, a company with R&D and GMP-compliant manufacturing facilities across US, EU and China, provides customer-centric innovative and reliable CDMO solutions for Small Molecules, Tides, Biologics, ADCs from pre-clinical to commercial.
R&D Scientists 1300+ | Customers 1000+ | Milestone Projects 3000+ | Total Capacity 2000+ m³
Link: www.portonpharma.com
Type: Service / Capability Showcase
Category:
CMC: Biologics, Drug Substance
CMC: Biologics, Drug Product
CMC: Biologics, Analytical
CMC: Small Molecules, Drug Substance
CMC: Small Molecules, Drug Product
CMC: Small Molecules, Analytical
Hashtags: #adc, #api, #cdmo, #cmc, #drugproduct, #drugsubstance, #manufacturing, #oligonucleotides, #peptides, #porton, #smallmolecules
BIO2BUSINESS LTD. London BioScience Innovation Centre, 2 Royal College Street, London. NW1 0NH.
Contact us by phone on +44 (0)207 691 3568; or by e-mail at [email protected]
Bio2BEvents Home | BOS Media pack for 2024 events
